Investment Type: Venture Capital
Investment Stage: Series A
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| 28.01.2022 | Ractigen T... | ractigen.com | $61M | China |
Mentions in press and media 2
| Date | Title | Description |
| 05.09.2025 | Immunofoco Earns Spot on Forbes Asia 100 to Watch 2025 List for Leading New Wave in Solid Tumor Cell Therapy | SHANGHAI, Sept. 5, 2025 /PRNewswire/ -- Immunofoco, a clinical-stage biotechnology company, focused on developing novel cell therapies for solid tumors, has been selected for the prestigious "Forbes Asia 100 to Watch 2025" list. T... |
| 24.06.2020 | Cambricon, once Huawei’s core AI chip supplier, eyes $400M IPO | One of China’s most valuable artificial intelligence chipmakers, Cambricon, is one step closer to its initial public offering, and its prospectus reveals a rare snapshot of where Chinese companies stand in relation to their international co... |